Granicip-1 DT (Granisetron HCL)
What is Granicip-1 DT (Granisetron HCL) used for?
Granicip-1 DT (Granisetron HCL) is given to patients to prevent nausea and vomiting caused by cancer treatment such as chemotherapy or radiotherapy. It may also be used to prevent nausea and vomiting after surgical procedures or operations. It works by blocking the action of serotonin, a chemical in the body which can trigger nausea and vomiting.
How should I use Granicip-1 DT (Granisetron HCL)?
The dosage for Granicip-1 DT (Granisetron HCL) depends on the condition being treated. If you are taking this medication to prevent vomiting and nausea caused by chemotherapy, you may be told to take it 1 hour prior to beginning chemotherapy, and a second dose may sometimes be taken 12 hours after taking the first. For patients undergoing radiotherapy, it is usually taken 1 hour prior to the commencement of radiotherapy.
What are the side effects of Granicip-1 DT (Granisetron HCL)?
Some patients taking Granicip-1 DT (Granisetron HCL) may experience:
If you notice any other more serious side effects when taking this medication, you should consult your physician.
Strictly follow all instructions provided to you by your physician or pharmacist while using Granicip-1 DT (Granisetron HCL). Optimum and safe dosage can differ based on the patient and the condition being treated.
As this medication may be unsafe for certain patients, it is essential you always inform your physician if you are pregnant or breastfeeding, as well as if you have any allergies, other illnesses, or ongoing health conditions, and if you are taking any other form of medication, supplements, or herbal products.
Immediately seek emergency medical care if you have any allergic or hypersensitive reaction. Common signs of a reaction include hives, swelling, skin rashes, chest pains, as well as trouble breathing or swallowing.